Abstract 096: Renal-Specific Deletion of (Pro)Renin Receptor in Mice Induces Hyperkalemia During High Potassium Intake
Chuanming Xu,Yanting Chen,Shiying Xie,Fei Wang,Renfei Luo,Tianxin Yang
DOI: https://doi.org/10.1161/hyp.74.suppl_1.096
IF: 9.8968
2019-01-01
Hypertension
Abstract:We have previously shown that systemic administration of (pro)renin receptor (PRR) decoy inhibitor PRO20 impaired kaliuretic response to high K + (HK) intake (5% KCl in diet). The present study extends this observation by examining the phenotype of inducible renal tubule-specific PRR knockout (RT PRR KO) mice fed a HK diet. The null mice were generated by breeding Floxed PRR mice with mice transgenic for Pax8-rtTA and LC-1 transgene. To induce RT PRR KO, mice with homozygous for Floxed PRR gene and hemizygous for the Pax8-rtTA and the LC-1 transgene were given 2 mg/ml doxycycline in 5% sucrose drinking water for 14 days followed by 4-wk off doxycycline. Following 1-wk HK intake, RT PRR KO mice had decreased urinary K + (by 33.6%) excretion and elevated plasma K + level (KO+HK: 5.38 ± 0.21 vs. Floxed+HK: 3.98 ± 0.03 mM, P <0.001), accompanied with a reduction of urinary prorenin/renin content (by 56.5%), urinary renin activity (by 69.6%), urinary free and total Aldo excretion (by 41.2% and 25.3%, respectively), and kidney cortical and medullary Aldo levels (by 62.0% and 64.2%, respectively), without affecting plasma Aldo or renin levels. HK upregulated renal protein expression of fPRR (cortical: 170.4%, medullary: 195.0%), sPRR (cortical: 138.0%, medullary: 180.1%), prorenin (cortical: 217.5%, medullary: 164.0%), renin (cortical: 183.2%, medullary: 153.1%), Aldo synthase CYP11B2 (cortical: 321.6%, medullary: 243.8%), ROMK (165.4%), α-BK (161.4%), α-Na + -K + -ATPase (160.3%), β-ENaC (130.2%), and cleaved-γ-ENaC (542.0%), and downregulated phosphorylated NCC-T53 (pNCC-T53) protein expression, all of which were significantly blunted in RT PRR KO mice (by 25-80%). In Flp-In T-REX 293 NCC cell line (stably expressing NCC), PRR siRNA significantly increased pNCC-T53 (by 72.3%) and partially reversed prorenin (100 nM)-induced inhibition of pNCC-T53 (by 38.2%). sPRR-His (10 nM) inhibited pNCC-T53 (by 48.9%), which were significantly reversed by losartan or angiotensin II receptor type 1 (AT1R) siRNA, without affecting total NCC expression. Together, these results suggest that PRR/sPRR contributes to the kaliuretic response through an impact on the intrarenal RAAS and the K + secretory machinery in the distal nephron.